Clinical trial
Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection, Platinum (Cisplatin/Carboplatin) Combined With Sindilizumab Injection in the First-line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
NCT05782426 is registered in ClinicalTrials.gov with Jiangsu Cancer Institute & Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection, Platinum (Cisplatin/Carboplatin) Combined With Sindilizumab Injection in the First-line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
- Lead sponsor
- Jiangsu Cancer Institute & Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 15, 2023
- Completion date
- January 31, 2026
- Enrollment
- 28 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
non-squamous nsclc